Most Recent Episode
Mesothelioma Foundation Board Member Cheryl Bruner, Esq. sits down with attorneys from Maune, Raichle, Hartley, French & Mudd (MRHFM) to answer some of the most common questions patients and families have about the legal process after a mesothelioma diagnosis.
In this informative discussion, they address concerns about whether a case will go to court, the financial implications of pursuing legal action, and what patients can expect regarding the timeline of litigation. They also explain how individuals can prepare for the process, what information may be needed, and why it is important to explore legal options as early as possible.
The conversation concludes with a look at what sets MRHFM apart, their commitment to serving mesothelioma patients and families, and their longstanding partnership with the Mesothelioma Foundation.
Whether you are newly diagnosed, a caregiver, or simply seeking information, this video provides valuable insights into navigating the legal aspects of mesothelioma with confidence and support.
Content:
00:00 Intro
3:16 What makes MRHFM stand out?
7:55 How does the Mesothelioma Foundation’s collaboration with MRHFM affect your clients?
13:38 How does MRHFM take care of veteran clients?
16:23 What is the approach to investigating clients’ claims?
17:48 Based on the investigation, what happens next?
19:18 What are the most common fears you hear when meeting a new client?
22:20 What concerns do you typically hear from clients about going to court?
23:32 What concerns do clients have on financial issues?
28:11 How long does the litigation process take?
30:30 What are some other concerns that clients have?
35:53 When should patients seek legal help?
38:23 Where does the money come from in claims and lawsuits?
39:40 What concerns are there around bankruptcy and still achieving justice?
42:17 How do you prove a case in civil litigation?
44:42 What do patients have to have?
45:30 What makes MRHFM so unique in representing mesothelioma patients?
This program is made possible by a generous educational grant from MRHFM.
Past Episodes
- Meet Joe Belluck
- Bring Closure to Mesothelioma Clients through the Legal Process
- Asbestos Litigation Experience Matters When Picking an Attorney
- What to Expect from Mesothelioma Litigation
- Asbestos Litigations Questions Answered
- Immunotherapy for mesothelioma: What’s Next?
- YOUR legal questions answered in this special legal edition of Meet the Mesothelioma Experts.
- Present and Future of Immunotherapy Treatment for Mesothelioma
- Meet the Mesothelioma Experts: Legal Edition w/ Maune Raichle Hartley French & Mudd, LLC (MRHFM) law firm
- Special MTME: Legal Edition with Joe Belluck, of Belluck & Fox, LLP
- Discussing the Tumor Treating Fields device for mesothelioma with Dr. Zachary Horne
- Pre-Operative Immunotherapy Clinical Trial with Dr. Patrick Forde of Johns Hopkins
- Mesothelioma Program at Veterans Affairs Medical Center in Houston, Texas
- Phase 3 Study of TR002, an adenovirus-mediated interferon alfa 2b with Dr. Steve Albelda & Dr. Daniel Sterman
- Breath test for early detection of mesothelioma is in the works with Dr. Michael Harbut
- Front-line clinical trial for non-epithelioid mesothelioma with Dr. Marjorie G. Zauderer and Dr. John Bomalaski
- An Interview with Aduro Biotech
- An Interview with William A. Franco and Julie P. Pawelczyk of The Conafay Group
- Targeting the Immune System with Daniel H. Sterman, MD
- Meet Marjorie Zauderer, MD, of Memorial Sloan Kettering Cancer Center
- Current Trends in Mesothelioma Surgery and Research: The International Mesothelioma Program at Brigham and Women’s Hospital
- 2015 Grant Recipient Interviews
- Focus on Centers of Excellence: Penn Medicine with Dr. Evan Alley and Dr. Charles Simone
- Focus on Mesothelioma Centers of Excellence with Dr. Hedy Lee Kindler
- CRS-207: Using a Modified Listeria Virus to Fight Mesothelioma with Aduro BioTech
- Mesothelioma Clinical Trial Using PD-L1 Inhibitors with Dr. Evan Alley
- Defactinib, a New Investigational Agent for Mesothelioma, with Dr. Joanna Horobin
- Focused Discussion of a New Clinical Trial: GL-ONC1 with Dr. Valerie Rusch
- New Frontiers in Surgery for Mesothelioma with Dr. Joseph Friedberg
- Designing Clinical Trials for Mesothelioma with Melissa Culligan, RN
- Intrapleural Measles Virus Therapy in patients with malignant pleural mesothelioma with Dr. Tobias Peikert
- NGR-hTTNF: A New Multi-Center Drug Trial for Pleural Mesothelioma with Dr. Julie Brahmer
- Mesothelin: A New Target for Immunotherapy with Dr. Raffit Hassan
- Recent Advances in Mesothelioma Gene Therapy with Dr. Daniel Sterman
- Vaccines: can we manipulate the immune system to prevent recurrence following a PD/EPP?